INJECTHEAL at the TCES Conference 2026

📍 June 2026 | Brighton, United Kingdom From 15 to 17 June 2026, the INJECTHEAL project was represented at the TCES Conference in Brighton, United Kingdom. During the poster session, our partners presented their work, sharing key advances about their contribution to the project with the scientific community. Key information about the posters: đź”— Download the posters via Zenodo: […]
INJECTHEAL 1st Dissemination Event – Lived Experience, Technological Innovation, and Clinical Application in Advanced Wound Care

On 17 June 2026, the Centre for Regenerative Medicine and Devices (CRMD) at the University of Brighton hosted the first Dissemination Event of the INJECTHEAL project, held in the framework of the Tissue & Cell Engineering Society (TCES) Conference. The event brought together scientific partners, researchers, healthcare professionals and stakeholders from the biomedical sector to […]
Research and innovation for new solutions in the treatment of chronic deep wounds: The first dissemination event for the European INJECTHEAL project will take place on 17 June in Brighton

Brighton, 17 June 2026 – On 17 June 2026, the Centre for Regenerative Medicine and Devices (CRMD) at the University of Brighton will host the first Dissemination Event of the European project INJECTHEAL, an initiative funded by the Horizon Europe programme and focused on the development of advanced technologies for the treatment of deep chronic […]
INJECTHEAL at TERMIS-EU 2026: Scientific Excellence and International Recognition

📍 April 2026 | Palma de Mallorca, Spain Several InjectHeal research groups proudly participated in the prestigious TERMIS-EU 2026 Conference, held in Palma de Mallorca, Spain, from April 21–24, 2026, one of the most important international events in the field of Tissue Engineering and Regenerative Medicine (TERM). 🗣️The Conference Organized by the Tissue Engineering and […]
“Injectable self-healing oxidized pectin and carbohydrazide-modified gelatin hydrogels for curcumin-loaded zein nanoparticle delivery in antioxidant therapy”

Publication | Journal: Biomaterials Science | January 2026 | DOI: 10.1039/d5bm01302j đź“„ About the publication: The design of drug delivery systems (DDS) for efficient and sustained in situ antioxidant treatment is a key challenge in regenerative medicine. In this work, the authors developed innovative and sustainable injectable hydrogels based on oxidized pectin (PDA) and carbohydrazide-modified […]
INJECTHEAL at the MDDB Conference 2026

📍 February 2026 | Lausanne, Switzerland From 3 to 5 February 2026, the INJECTHEAL project was represented at the MDDB Conference in Lausanne, Switzerland. During the poster session, our partners SUPSI presented their work, sharing key advances about their contribution to the project with the scientific community. About the poster: The poster showcased the development […]
INJECHTEAL Patient Brochure Now Available

The INJECTHEAL project has released its official Patient Brochure. This tri-fold brochure has been designed to provide clear, accessible information for patients and end‑users, highlighting the project’s social impact and the benefits of the innovative self‑healing injectable hydrogel for chronic wound care. Download the complete brochure here
INJECHTEAL Project Brochure Now Available

The official INJECTHEAL brochure is now accessible online. It provides a comprehensive overview of the project’s objectives, innovative technology, target groups, consortium structure, and key contact information. Download the complete brochure here